Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluation of a Bayesian method for predicting vancomycin dosing.

M E Burton1, D L Gentle, M R Vasko

  • 1Clinical Pharmacology Section, Veterans Administration Medical Center, Dallas, TX 75216.

DICP : the Annals of Pharmacotherapy
|April 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ras signaling pathways mediate NGF-induced enhancement of excitability of small-diameter capsaicin-sensitive sensory neurons from wildtype but not Nf1+/- mice.

Neuroscience letters·2011
Same author

Vasodilatation in the rat dorsal hindpaw induced by activation of sensory neurons is reduced by paclitaxel.

Neurotoxicology·2010
Same author

Signaling pathways that mediate nerve growth factor-induced increase in expression and release of calcitonin gene-related peptide from sensory neurons.

Neuroscience·2010
Same author

Silencing S1P1 receptors regulates collagen-V reactive lymphocyte-mediated immunobiology in the transplanted lung.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same author

Spinal N-methyl-D-aspartate receptors and nociception-evoked release of primary afferent substance P.

Neuroscience·2008
Same author

Intracellular sphingosine 1-phosphate mediates the increased excitability produced by nerve growth factor in rat sensory neurons.

The Journal of physiology·2006
Same journal

Eradication of methicillin-resistant Staphylococcus aureus vaginitis with mupirocin.

DICP : the annals of pharmacotherapy·1991
Same journal

Ketorolac formulary restriction and usage evaluation.

DICP : the annals of pharmacotherapy·1991
Same journal

Oral vancomycin-induced rash: case report and review of the literature.

DICP : the annals of pharmacotherapy·1991
Same journal

Imipenem/cilastatin drug utilization evaluation in a large community hospital.

DICP : the annals of pharmacotherapy·1991
Same journal

Pharmacist involvement in Society of Critical Care Medicine.

DICP : the annals of pharmacotherapy·1991
Same journal

Early anticoagulation therapy in deep vein thrombosis.

DICP : the annals of pharmacotherapy·1991
See all related articles

This study shows that a Bayesian vancomycin dosing program significantly improves prediction accuracy for serum vancomycin concentrations, reducing dosing errors in patients, including those with renal impairment.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Pharmacometrics

Background:

  • Accurate vancomycin dosing is crucial for therapeutic efficacy and minimizing toxicity.
  • Traditional dosing relies on population pharmacokinetic parameters, which may not be optimal for individual patients.
  • Bayesian methods offer a way to individualize vancomycin dosing using patient-specific data.

Purpose of the Study:

  • To evaluate the performance of a vancomycin dosing program in predicting target serum concentrations.
  • To assess the impact of revised pharmacokinetic parameters on program accuracy.
  • To determine the effectiveness of a Bayesian algorithm for individualizing vancomycin dosage.

Main Methods:

  • A vancomycin dosing program utilizing population estimates of volume of distribution (Vd) and clearance (Cl) was evaluated.

Related Experiment Videos

  • A Bayesian algorithm was employed to individualize pharmacokinetic parameters using dosing and serum concentration data.
  • Program performance was assessed by comparing predicted minus observed vancomycin concentrations (accuracy and bias).

    • Main Results:

    • Bayesian individualized dosing significantly improved accuracy for both peak and trough vancomycin concentrations compared to population estimates.
    • Increased iterations of the Bayesian algorithm led to significant adjustments in Vd and Cl estimates.
    • The Bayesian forecaster demonstrated improved dosing accuracy in patients with impaired renal function.

    Conclusions:

    • The Bayesian vancomycin dosing method provides accurate and unbiased individualized dose predictions.
    • Revised pharmacokinetic parameter estimates derived from Bayesian analysis enhance program performance.
    • This approach is particularly beneficial for optimizing vancomycin therapy in diverse patient populations, including those with renal dysfunction.